Best deals to access real time data! |
|
Big Cap Pro
Monthly Subscription
for only
|
|
Small Cap Pro
Monthly Subscription
for only
|
|
DDE w/Realtime (Monthly)
Monthly Subscription
for only
|
|
VAT not included
|
|
After Hours Last Trade |
Last: $ 1.38 ▼ -0.04 (-2.82%) | |
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Aclaris Therapeutics Inc | ACRS | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | High Price | Low Price | Open Price | Close Price | Last Traded  |
|
|---|---|---|---|---|---|---|---|---|
| 0.03 | 2.16% | 1.42 | 1.54 | 1.37 | 1.43 | 1.39 | 19:17:39 |
| Bid Price | Ask Price | Spread | Spread % | News | |
|---|---|---|---|---|---|
| 1.38 | 1.45 | 0.07 | 4.83% | - | - |
| Stock Trades | Traded Volume | VWAP | Dollar Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 4,345 | 1,758,994 | $ 1.43 | $ 2,508,516 | 2,555,348 | 0.74 - 15.98 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 19:55:41 | 3 | $ 1.40 | USD |
Aclaris Therapeutics Financials
| Market Cap | Shares in Issue | Profit/Loss | Earnings Per Share (EPS) | PE Ratio | Float |
|---|---|---|---|---|---|
| $ 58.74M | 41.37M | $ -132.74M | -4.04 | - | 39.59M |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | 0.00% | - | - |
Aclaris Therapeutics News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical ACRS Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol [m] | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 1.11 | 2.32 | 1 | 1.7240 | 9M | 0.31 | 27.93% |
| 1 Month | 1.12 | 2.32 | 0.8585 | 1.6139 | 3M | 0.3 | 26.79% |
| 3 Months | 2.28 | 2.5 | 0.74 | 1.4656 | 2M | -0.86 | -37.72% |
| 6 Months | 6.85 | 7.1531 | 0.74 | 2.5316 | 1M | -5.43 | -79.27% |
| 1 Year | 15.52 | 15.98 | 0.74 | 4.4505 | 803k | -14.1 | -90.85% |
| 3 Years | 24.27 | 33.25 | 0.74 | 12.2589 | 446k | -22.85 | -94.15% |
| 5 Years | 11.94 | 33.88 | 0.74 | 12.5454 | 353k | -10.52 | -88.11% |
Aclaris Therapeutics Description
| Aclaris Therapeutics Inc is a clinical-stage specialty pharmaceutical company which operates in United States. It focuses on identifying, developing and commercializing differentiated drugs to address significant unmet needs in dermatology. The company holds a drug candidate, A-101 Topical Solution which is a proprietary high-concentration hydrogen peroxide topical solution which is being developed as a prescription treatment for seborrheic keratosis (SK) a common non-malignant skin tumor. Its pipeline of drug candidates includes A-101 as a Topical Solution for treatment of SK, common warts; A-102 as a gel dosage form for treatment of SK and warts and A-201 and A-301 as an oral and topical formulation for treatment of autoimmune dermatologic respectively. |
